Skip to content

Evaluation of a Clinical Decision Support System for Fungal Infections

Evaluation of a Clinical Decision Support System for the Treatment of Invasive Fungal Infections

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05656157
Enrollment
278
Registered
2022-12-19
Start date
2022-12-01
Completion date
2023-11-30
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Fungal Infections

Keywords

invasive fungal infections, antifungal treatment, clinical decision support system

Brief summary

Invasive fungal infections are serious and frequent diseases in our hospitals, especially in intensive care units. In accordance with the institutional recommendations, it is necessary to have a clinical decision support system to support the clinicians in a rapid and optimal prescription of antifungals for invasive fungal diseases. This clinical decision support system will benefit patients but also clinicians who will gain in medical efficiency. It will also have an ethical dimension since it will guarantee optimal antifungal treatments for all patients. The purpose of the research is to define the percentage of concordance between the medical prescription and the recommendation of the clinical decision support system.

Interventions

DEVICEMedical device

Clinical decision support system

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients receiving antifungal therapy for the treatment of invasive fungal disease

Exclusion criteria

* Patients not receiving antifungal therapy for the treatment of invasive fungal disease

Design outcomes

Primary

MeasureTime frame
Percentage of concordance between the medical prescription and the recommendation of the clinical decision support systemJanuary to september 2023

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026